Printer-friendly version
Dermavest® is a skin replacement derived from particularized, decellularized human placental tissue extracellular matrix.
• Five times the connective tissue of amnion-chorion alone
• Easy to handle
• Swells to flow over the wound and cover more area
• Complete contact with wound eliminates separation from bed
Dermavest® is indicated for use on diabetic ulcers, pressure ulcers, burns, venous ulcers, and post-Mohs surgery.
Contraindicated for use on individuals with a known sensitivity to the product or its components.
Store at room temperature. Three year shelf life.
Human placental connective tissue matrix
| Assigned HCPCS code | ● |
| Minimally manipulated | |
| Cryopreserved | |
| Dehydrated | |
| Desiccated | |
| Flowable | |
| Micronized | ● |
| Sheet form | |
| Requires refrigeration | |
| Shelf life greater than 2 years | ● |
| Shelf life limited | |
| Indicated for acute wounds | ● |
| Indicated for chronic wounds | ● |
| Indicated for diabetic ulcers | ● |
| Indicated for pressure ulcers | ● |
| Indicated for surgical wounds | ● |
| Indicated for third-degree burns | |
| Indicated for venous ulcers | ● |
| Contact manufacturer for usage guidelines |
Acute Wounds
Burns
Cavity Wounds
Chronic Wounds
Deep Wounds
Dehisced Wounds
Diabetic Foot
Pressure Ulcers
Surgical Wounds
Venous Ulcers
Carefully place Dermavest® onto the area of application. Tear pieces as needed.
Change as needed.
Cover with a non-adherent dressing.
Non-cytotoxic
Non-irritating
Aedicell is a regenerative medicine company that has developed a unique proprietary process to transform human tissue into a biologic for therapy.